Clinical Trial Update: A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety, efficacy, and pharmacodynamics of dasiglucagon as a hypoglycemia rescue therapy in children under 6 years with Type 1 dia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• Zegalogue (dasiglucagon)

Snippet

Sponsor: Zealand Pharma | Conditions: Hypoglycemia, Type 1 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2025-07-20